The authors explore the molecular mechanisms regulating the crosstalk and interaction of transcription factor AhR with cancer-related signaling pathways, such as apoptosis, epithelial-mesenchymal transition, immune checkpoints, and G-protein-coupled receptors in gynecological malignancies such as ovarian, uterine, and endometrial, and cervical cancers.
[Seminars in Cancer Biology]
